Anti-Inflammatory Effects Of Frequency Specific Microcurrent (FSM) In Osteoarthritic Adults
- Disease/Condition
- Osteoarthritis
- Drug/Device/Intervention
- Frequency Specific Microcurrent
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Nova Southeastern University
- Phase
- N/A
- Start date
- Apr 01, 2024
- End date
- May 01, 2024
- Enrollment
- 12 participants
Interleukin-6
It is hypothesized that application of frequency specific microcurrent can decrease
 inflammation in osteoarthritis patients resulting in decreased pain and potentially decrease
 disease progression. Participants will received the microcurrent treatment for one hour and a
 total of five blood draws to measure inflammatory markers. Participants will also complete a
 pre and post treatment pain questionnaire.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06390137
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06390137 through Pure Global AI's free database. This phase not specified trial is sponsored by Nova Southeastern University and is currently Not yet recruiting. The study focuses on Osteoarthritis. Target enrollment is 12 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.